Skip to main content

The ARCHIE study will find out whether giving an antibiotic called co-amoxiclav to children aged 6 months to 12 years with a long term condition (‘at risk’) early on when they have flu or flu-like illness might:

  • Help prevent  them developing secondary bacterial infections
  • Help them get better more quickly
  • Affect how well antibiotics work against similar infections in future.